Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI

Archive ouverte

Guerard, Marie | Robin, Thomas | Perron, Pascal | Hatat, Anne-Sophie | David-Boudet, Laurence | Vanwonterghem, Laetitia | Busser, Benoît | Coll, Jean-Luc | Lantuejoul, Sylvie | Eymin, Béatrice | Hurbin, Amandine | Gazzeri, Sylvie

Edité par CCSD ; Elsevier -

International audience. Many Receptor Tyrosine Kinases translocate from the cell surface to the nucleus in normal and pathological conditions, including cancer. Here we report the nuclear expression of insulin-like growth factor-1 receptor (IGF1R) in primary human lung tumours. Using lung cancer cell lines and lung tumour xeno-grafts, we demonstrate that the epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) gefitinib induces the nuclear accumulation of IGF1R in mucinous lung adenocarcinoma by a mechanism involving the intracellular re-localization of the growth factor amphiregulin. Amphiregulin allows the binding of IGF1R to importin-b1 and promotes its nuclear transport. The nuclear accumulation of IGF1R by amphiregulin induces cell cycle arrest through p21 WAF1/CIP1 upregulation, and prevents the induction of apoptosis in response to gefitinib. These results identify amphiregulin as the first nuclear localization signal-containing protein that interacts with IGF1R and allows its nuclear translocation. Furthermore they indicate that nuclear expression of IGF1R contributes to EGFR-TKI resistance in lung cancer.

Suggestions

Du même auteur

Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival

Archive ouverte | Dayde, Delphine | CCSD

International audience

ARF promotes the degradation of the Epidermal Growth Factor Receptor by the lysosome

Archive ouverte | Beaumont, Anaïs | CCSD

International audience. Epidermal Growth Factor Receptor (EGFR) signaling regulates multiple cellular processes including proliferation , survival and apoptosis, and is attenuated by lysosomal receptor degradation. ...

The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivo

Archive ouverte | Gilson, Pauline | CCSD

International audience. Standard chemotherapies that interfere with microtubule dynamics are a chemotherapeutic option used for the patients with advanced malignancies that invariably relapse after targeted therapie...

Chargement des enrichissements...